Alcohol Use Disorder: Symptoms, Risks, Withdrawal, and Treatment

Introduction

Alcohol use disorder (AUD) is the most prevalent substance use disorder in the United States and one of the leading causes of preventable death worldwide. According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), approximately 29.5 million Americans aged 12 and older had AUD in 2021. Despite its prevalence and the availability of effective treatments, fewer than 10% of people with AUD receive any form of treatment — a treatment gap driven by stigma, lack of access, and inadequate recognition of the disorder.

AUD is not simply "drinking too much." It is a chronic brain disorder characterized by compulsive alcohol use, loss of control over drinking, and a negative emotional state when not drinking. Understanding AUD as a medical condition — with identifiable causes, mechanisms, and treatments — is essential for reducing stigma and improving treatment outcomes.

Key Definitions

Alcohol use disorder (AUD): A medical condition characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. Diagnosed using DSM-5 criteria.

Standard drink: In the United States, a standard drink contains approximately 14 grams of pure alcohol — equivalent to 12 oz of regular beer (5% ABV), 5 oz of wine (12% ABV), or 1.5 oz of distilled spirits (40% ABV).

Heavy drinking: For men, more than 4 drinks on any day or more than 14 drinks per week. For women, more than 3 drinks on any day or more than 7 drinks per week.

Binge drinking: A pattern of drinking that brings blood alcohol concentration to 0.08% or higher — typically 4+ drinks for women and 5+ drinks for men within about 2 hours.

Alcohol withdrawal syndrome: The physiological symptoms that occur when a person with physical dependence on alcohol stops or significantly reduces drinking.

DSM-5 Diagnostic Criteria

The DSM-5 defines AUD as a problematic pattern of alcohol use leading to clinically significant impairment or distress, manifested by at least 2 of the following 11 criteria within a 12-month period:

1. Alcohol is often taken in larger amounts or over a longer period than intended.
2. There is a persistent desire or unsuccessful efforts to cut down or control alcohol use.
3. A great deal of time is spent in activities necessary to obtain alcohol, use alcohol, or recover from its effects.
4. Craving, or a strong desire or urge to use alcohol.
5. Recurrent alcohol use resulting in a failure to fulfill major role obligations at work, school, or home.
6. Continued alcohol use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of alcohol.
7. Important social, occupational, or recreational activities are given up or reduced because of alcohol use.
8. Recurrent alcohol use in situations in which it is physically hazardous.
9. Alcohol use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by alcohol.
10. Tolerance, as defined by either a need for markedly increased amounts of alcohol to achieve intoxication or desired effect, or a markedly diminished effect with continued use of the same amount of alcohol.
11. Withdrawal, as manifested by either the characteristic alcohol withdrawal syndrome, or alcohol (or a closely related substance) is taken to relieve or avoid withdrawal symptoms.

Severity is specified as mild (2-3 criteria), moderate (4-5 criteria), or severe (6 or more criteria).

Health Risks of Alcohol Use Disorder

AUD is associated with a wide range of serious health consequences:

Liver disease: Alcohol is the leading cause of liver disease in the United States. Progression typically follows a continuum: alcoholic fatty liver (steatosis) → alcoholic hepatitis → cirrhosis. Approximately 10-20% of heavy drinkers develop cirrhosis. Alcoholic liver disease is the third leading cause of liver transplantation in the United States.

Cardiovascular disease: Heavy drinking increases the risk of cardiomyopathy (weakening of the heart muscle), arrhythmias (particularly atrial fibrillation), hypertension, and stroke. The relationship between alcohol and cardiovascular disease is complex — moderate drinking has been associated with reduced cardiovascular risk in some studies, though this association is controversial and may reflect confounding factors.

Cancer: Alcohol is a Group 1 carcinogen (the highest risk category) according to the International Agency for Research on Cancer. It is causally associated with cancers of the mouth, pharynx, larynx, esophagus, liver, colon, rectum, and breast. The risk increases with the amount consumed and is not limited to heavy drinkers — even moderate drinking increases cancer risk.

Neurological effects: Chronic heavy drinking can cause Wernicke-Korsakoff syndrome (a severe memory disorder caused by thiamine deficiency), peripheral neuropathy, cerebellar atrophy, and cognitive impairment. These neurological effects can be partially reversed with abstinence and thiamine supplementation.

Mental health: AUD is strongly associated with depression, anxiety, PTSD, and other mental health disorders. The relationship is bidirectional — mental health disorders increase AUD risk, and AUD worsens mental health outcomes.

Social consequences: AUD is associated with relationship problems, divorce, job loss, financial difficulties, legal problems (including DUI), and social isolation.

Alcohol Withdrawal: Recognition and Management

Alcohol withdrawal can be life-threatening and requires medical attention. The severity of withdrawal depends on the duration and amount of drinking, previous withdrawal history, and individual factors.

Timeline of alcohol withdrawal:

• 6-24 hours: Mild symptoms — anxiety, tremor, sweating, nausea, headache, insomnia.
• 24-48 hours: Moderate symptoms — increased anxiety, tremor, hypertension, tachycardia. Seizures can occur in this window.
• 48-72 hours: Peak severity. Delirium tremens (DTs) can develop — characterized by severe confusion, agitation, hallucinations, fever, and autonomic instability. DTs carry a mortality rate of 5-15% if untreated.
• Days 4-7: Gradual resolution of acute symptoms in most cases.

Medical management: Benzodiazepines are the first-line treatment for alcohol withdrawal, as they enhance GABA function and prevent seizures. Thiamine (vitamin B1) supplementation is essential to prevent Wernicke encephalopathy. Severe withdrawal requires inpatient medical management.

Treatment Options

Multiple evidence-based treatments are available for AUD:

Medications:

• Naltrexone: Reduces the rewarding effects of alcohol by blocking opioid receptors. Available as a daily oral tablet or monthly injection (Vivitrol). Reduces drinking days and heavy drinking days. Most effective in people with strong craving and family history of AUD.
• Acamprosate: Reduces the neural hyperexcitability that drives alcohol craving in abstinent people. Most effective in people who are already abstinent and want to maintain abstinence.
• Disulfiram (Antabuse): Produces an aversive reaction (flushing, nausea, vomiting) when alcohol is consumed, by blocking alcohol metabolism. Effective as a deterrent when adherence is monitored.
• Gabapentin: Reduces alcohol withdrawal symptoms and craving. Increasingly used off-label for AUD.

Behavioral therapies:

• Cognitive Behavioral Therapy (CBT): Identifies and modifies thoughts and behaviors that contribute to drinking. Builds coping skills for managing triggers and cravings.
• Motivational Enhancement Therapy (MET): Builds motivation for change through reflective listening and goal-setting.
• Twelve-Step Facilitation: Encourages engagement with AA and the 12-step program.
• Behavioral Couples Therapy: Involves the partner in treatment, improving both relationship functioning and drinking outcomes.

Mutual support groups: Alcoholics Anonymous (AA) is the most widely available mutual support group for AUD. Research has found that AA participation is associated with improved long-term outcomes, comparable to those achieved with formal treatment. SMART Recovery offers a secular, evidence-based alternative.

Long-Term Recovery Outcomes

AUD is a chronic condition, and recovery is a long-term process. Research on long-term outcomes shows:

• Approximately one-third of people with AUD have no further symptoms one year after treatment.
• Long-term recovery rates improve with sustained engagement in treatment and mutual support.
• Many people with AUD achieve stable, long-term recovery — defined as no symptoms for 4+ years — with appropriate treatment and support.
• Relapse is common but does not indicate treatment failure — it is a signal that treatment needs to be adjusted.

Frequently Asked Questions

Is AUD the same as alcoholism?
"Alcoholism" is a colloquial term that roughly corresponds to what is now clinically called alcohol use disorder. The DSM-5 replaced the older categories of "alcohol abuse" and "alcohol dependence" with the single diagnosis of AUD, which exists on a spectrum of severity.

Can people with AUD ever drink moderately?
For most people with moderate to severe AUD, abstinence is the recommended goal. Some people with mild AUD may be able to achieve controlled drinking, but this is not appropriate for most people with the disorder. The safest goal for most people with AUD is complete abstinence.

Is AUD hereditary?
Genetic factors account for approximately 50-60% of AUD risk. Having a first-degree relative with AUD significantly increases risk. However, genetics is not destiny — environmental factors, treatment, and lifestyle choices all influence outcomes.

What is the most effective treatment for AUD?
Research supports a combination of medication (particularly naltrexone or acamprosate) and behavioral therapy as the most effective approach. Engagement with mutual support groups (AA or SMART Recovery) further improves outcomes. The best treatment is the one that the individual will engage with consistently.

Key Takeaways

• AUD is a chronic brain disorder affecting approximately 29.5 million Americans, with fewer than 10% receiving treatment.
• AUD is diagnosed using DSM-5 criteria and exists on a spectrum of mild, moderate, and severe.
• Alcohol withdrawal can be life-threatening and requires medical management.
• Multiple evidence-based treatments are available, including naltrexone, acamprosate, CBT, and mutual support groups.
• Long-term recovery is achievable with appropriate treatment and support.

Additional Resources

Related articles on Sobriety Navigator: GABA, Glutamate, and Addiction, Medication-Assisted Treatment, Cognitive Behavioral Therapy for Addiction, Stages of Recovery.